5 Health Services Stocks Moving The Industry Upward

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 18 points (0.1%) at 15,482 as of Monday, July 15, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,893 issues advancing vs. 1,042 declining with 108 unchanged.

The Health Services industry currently sits up 0.7% versus the S&P 500, which is up 0.1%. Top gainers within the industry include WellCare Health Plans ( WCG), up 3.3%, Centene Corporation ( CNC), up 1.6%, Cooper Companies ( COO), up 1.4%, CareFusion ( CFN), up 1.1% and Laboratory Corporation of America Holdings ( LH), up 0.8%. On the negative front, top decliners within the industry include MiMedx Group ( MDXG), down 8.1%, and Fresenius Medical Care AG & Co. KGaA ( FMS), down 0.7%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Stryker Corporation ( SYK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Stryker Corporation is up $0.49 (0.7%) to $67.92 on light volume. Thus far, 262,990 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $67.34-$67.96 after having opened the day at $67.41 as compared to the previous trading day's close of $67.43.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $25.5 billion and is part of the health care sector. Shares are up 22.9% year to date as of the close of trading on Friday. Currently there are 15 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Catamaran ( CTRX) is up $0.54 (1.1%) to $49.78 on average volume. Thus far, 828,108 shares of Catamaran exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $49.52-$50.17 after having opened the day at $50.10 as compared to the previous trading day's close of $49.24.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $10.0 billion and is part of the health care sector. Shares are up 3.5% year to date as of the close of trading on Friday. Currently there are 16 analysts that rate Catamaran a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, compelling growth in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Catamaran Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, St Jude Medical ( STJ) is up $0.38 (0.8%) to $48.79 on light volume. Thus far, 423,277 shares of St Jude Medical exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $48.21-$48.83 after having opened the day at $48.33 as compared to the previous trading day's close of $48.41.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $13.6 billion and is part of the health care sector. Shares are up 32.7% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate St Jude Medical a buy, 2 analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, increase in net income, notable return on equity, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full St Jude Medical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Agilent Technologies ( A) is up $0.22 (0.5%) to $45.97 on light volume. Thus far, 955,753 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 3.7 million shares. The stock has ranged in price between $45.68-$46.28 after having opened the day at $45.70 as compared to the previous trading day's close of $45.75.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $15.7 billion and is part of the health care sector. Shares are up 11.7% year to date as of the close of trading on Friday. Currently there are 13 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Medtronic ( MDT) is up $0.29 (0.5%) to $53.73 on light volume. Thus far, 1.7 million shares of Medtronic exchanged hands as compared to its average daily volume of 5.0 million shares. The stock has ranged in price between $53.52-$53.85 after having opened the day at $53.58 as compared to the previous trading day's close of $53.44.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $54.1 billion and is part of the health care sector. Shares are up 31.0% year to date as of the close of trading on Friday. Currently there are 8 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medtronic Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Stocks Need to Move Lower to Be Able to Move Higher Again: Market Recon

Stocks Need to Move Lower to Be Able to Move Higher Again: Market Recon

11 Stocks Our Experts Love for November

11 Stocks Our Experts Love for November

Remember That Bumps in the Road Are Normal: Market Recon

Remember That Bumps in the Road Are Normal: Market Recon

Smith & Nephew Surges to Record High on Reports of Elliott Stake

Smith & Nephew Surges to Record High on Reports of Elliott Stake

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course